SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

FDC - Quaterly Results

11 Nov 2021 Evaluate
The revenue zoomed 5.52% to Rs. 3962.85 millions for the quarter ended September 2021 as compared to Rs. 3755.38 millions during the corresponding quarter last year.The Net Profit of the company registered a slight decline of -19.28% to Rs. 735.51  millions from Rs. 911.19 millions.Operating Profit reported a sharp decline to 1027.19 millions from 1279.15 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 3962.85 3755.38 5.52 8412.47 6816.26 23.42 13254.49 13310.93 -0.42
Other Income 305.76 187.71 62.89 540.10 467.39 15.56 971.46 826.58 17.53
PBIDT 1027.19 1279.15 -19.70 2401.95 2578.70 -6.85 4214.76 3662.37 15.08
Interest 7.17 8.19 -12.45 15.17 15.68 -3.25 34.02 34.15 -0.38
PBDT 1020.02 1270.96 -19.74 2386.78 2563.02 -6.88 4180.74 3628.22 15.23
Depreciation 94.36 95.99 -1.70 189.31 190.13 -0.43 376.23 373.63 0.70
PBT 925.66 1174.97 -21.22 2197.47 2372.89 -7.39 3804.51 3254.59 16.90
TAX 190.15 263.78 -27.91 460.87 555.45 -17.03 859.61 786.81 9.25
Deferred Tax 0.15 -9.22 -101.63 -40.13 -22.55 77.96 14.45 -41.19 -135.08
PAT 735.51 911.19 -19.28 1736.60 1817.44 -4.45 2944.90 2467.78 19.33
Equity 168.81 170.97 -1.26 168.81 170.97 -1.26 168.81 170.97 -1.26
PBIDTM(%) 25.92 34.06 -23.90 28.55 37.83 -24.53 31.80 27.51 15.57

FDC Share Price

358.65 2.60 (0.73%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×